Literature DB >> 31977602

Deep-Learning Generated Synthetic Double Inversion Recovery Images Improve Multiple Sclerosis Lesion Detection.

Tom Finck1, Hongwei Li2, Lioba Grundl1, Paul Eichinger1, Matthias Bussas, Mark Mühlau, Bjoern Menze2, Benedikt Wiestler.   

Abstract

OBJECTIVES: The aim of the study was to implement a deep-learning tool to produce synthetic double inversion recovery (synthDIR) images and compare their diagnostic performance to conventional sequences in patients with multiple sclerosis (MS).
MATERIALS AND METHODS: For this retrospective analysis, 100 MS patients (65 female, 37 [22-68] years) were randomly selected from a prospective observational cohort between 2014 and 2016. In a subset of 50 patients, an artificial neural network (DiamondGAN) was trained to generate a synthetic DIR (synthDIR) from standard acquisitions (T1, T2, and fluid-attenuated inversion recovery [FLAIR]). With the resulting network, synthDIR was generated for the remaining 50 subjects. These images as well as conventionally acquired DIR (trueDIR) and FLAIR images were assessed for MS lesions by 2 independent readers, blinded to the source of the DIR image. Lesion counts in the different modalities were compared using a Wilcoxon signed-rank test, and interrater analysis was performed. Contrast-to-noise ratios were compared for objective image quality.
RESULTS: Utilization of synthDIR allowed to detect significantly more lesions compared with the use of FLAIR images (31.4 ± 20.7 vs 22.8 ± 12.7, P < 0.001). This improvement was mainly attributable to an improved depiction of juxtacortical lesions (12.3 ± 10.8 vs 7.2 ± 5.6, P < 0.001). Interrater reliability was excellent in FLAIR 0.92 (95% confidence interval [CI], 0.85-0.95), synthDIR 0.93 (95% CI, 0.87-0.96), and trueDIR 0.95 (95% CI, 0.85-0.98).Contrast-to-noise ratio in synthDIR exceeded that of FLAIR (22.0 ± 6.4 vs 16.7 ± 3.6, P = 0.009); no significant difference was seen in comparison to trueDIR (22.0 ± 6.4 vs 22.4 ± 7.9, P = 0.87).
CONCLUSIONS: Computationally generated DIR images improve lesion depiction compared with the use of standard modalities. This method demonstrates how artificial intelligence can help improving imaging in specific pathologies.

Entities:  

Year:  2020        PMID: 31977602     DOI: 10.1097/RLI.0000000000000640

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

Review 1.  The role of generative adversarial networks in brain MRI: a scoping review.

Authors:  Hazrat Ali; Md Rafiul Biswas; Farida Mohsen; Uzair Shah; Asma Alamgir; Osama Mousa; Zubair Shah
Journal:  Insights Imaging       Date:  2022-06-04

2.  Convolutional Neural Network Based Frameworks for Fast Automatic Segmentation of Thalamic Nuclei from Native and Synthesized Contrast Structural MRI.

Authors:  Lavanya Umapathy; Mahesh Bharath Keerthivasan; Natalie M Zahr; Ali Bilgin; Manojkumar Saranathan
Journal:  Neuroinformatics       Date:  2021-10-09

3.  3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions.

Authors:  S Fujita; K Yokoyama; A Hagiwara; S Kato; C Andica; K Kamagata; N Hattori; O Abe; S Aoki
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-07       Impact factor: 3.825

4.  Navigator-Guided Motion and B0 Correction of T2*-Weighted Magnetic Resonance Imaging Improves Multiple Sclerosis Cortical Lesion Detection.

Authors:  Jiaen Liu; Erin S Beck; Stefano Filippini; Peter van Gelderen; Jacco A de Zwart; Gina Norato; Pascal Sati; Omar Al-Louzi; Hadar Kolb; Maxime Donadieu; Mark Morrison; Jeff H Duyn; Daniel S Reich
Journal:  Invest Radiol       Date:  2021-07-01       Impact factor: 10.065

5.  Artificial double inversion recovery images can substitute conventionally acquired images: an MRI-histology study.

Authors:  Piet M Bouman; Martijn D Steenwijk; Jeroen J G Geurts; Laura E Jonkman
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

6.  Uncertainty-Aware and Lesion-Specific Image Synthesis in Multiple Sclerosis Magnetic Resonance Imaging: A Multicentric Validation Study.

Authors:  Tom Finck; Hongwei Li; Sarah Schlaeger; Lioba Grundl; Nico Sollmann; Benjamin Bender; Eva Bürkle; Claus Zimmer; Jan Kirschke; Björn Menze; Mark Mühlau; Benedikt Wiestler
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.